Abstract:Background: Diabetic nephropathy is one of the most common complications associated with diabetes. However, non-diabetic kidney disease has been reported in patients with type 2 diabetes at varying incidence rates. The objective of our study is to investigate the occurrence, clinicopathological characteristics, and inflammatory markers linked to diabetic and non-diabetic nephropathy (NDN) in patients with type 2 diabetes mellitus (DM). Additionally, we aimed to explore the possibility of identifying non-diabetic pathology using different biopsy indications. Materials and methods: A total of 159 patients with type 2 DM who underwent renal biopsy at a tertiary care nephrology clinic between January 2000 and January 2022 were enrolled in the study. We collected comprehensive data, including patient demographics, co-morbidities, diabetes duration, renal biopsy indications and results, serological markers, renal function, diabetic retinopathy (DRP), full blood count, blood biochemistry, urinalysis, and inflammatory markers. Patients were categorized based on their biopsy indications, and their biopsy results were classified into three groups: isolated NDN, isolated diabetic nephropathy (DN), and mixed nephropathy with concurrent NDN. We evaluated the relationship between biopsy indications and accompanying pathologies and statistically assessed the likelihood of each biopsy indication detecting non-diabetic renal pathology. Additionally, differences in other data, including demographic and laboratory results and medical histories, among the three groups were investigated. Results: The most frequent indication of renal biopsy was atypical presentations of nephrotic syndrome or nephrotic range proteinuria (ANS/ANP) in 25.1% of patients. Other indications included unexplained renal failure (URF) in 22.6%, atypical presentations of non-nephrotic range proteinuria (ANNP) in 18.2%, acute kidney injury or rapidly progressive kidney dysfunction (AKI/RPKD) in 16.9%, microscopic hematuria in 15.7%, URF with ANNP in 11.3%, and severe nephrotic range proteinuria (SNP) in 9.4%. Renal biopsy revealed isolated NDN in 64.8%, DN in 25.1%, and mixed nephropathy in 10.1% of patients. Primary glomerular diseases were the main non-diabetic renal pathology, predominantly focal segmental glomerulosclerosis (FSGS) (36.4%) followed by MN (10.6%) and IgA nephropathy (7.5%). In comparison with the isolated DN and mixed nephropathy groups, patients in the isolated NDN group had significantly shorter diabetes duration, fewer DRP, as well as lower serum creatinine and neutrophil-to-lymphocyte ratio (NLR). Multivariate logistic regression analysis revealed that presence of hematuria (OR 4.40; 95% CI 1.34 - 14.46, p = 0.014), acute nephrotic range proteinuria (OR 11.93; 95% CI 1.56 - 90.77, p = 0.017), and AKI/APKD (OR 41.08; 95% CI 3.40 - 495.39, p = 0.003) were strong predictors of NDN. Lower NLR (OR 0.77; 95% CI 0.60 - 0.98, p = 0.035), shorter duration of diabetes (OR 0.90; 95% CI 0.84 - 0.97, p = 0.010), and absence of DRP (OR 0.35; 95% CI 0.12 - 0.98, p = 0.046) were also found to be independent indicators of NDN. Receiver operating characteristic curve (ROC) analysis revealed a cut-off value of ≤ 3.01 for NLR (sensitivity of 63.1%, specificity of 63.5%) with regards to predicting non-diabetic renal pathology (p = 0.006). Conclusion: Renal biopsy findings in patients with type 2 DM highlight that the prevalence of NDN may be higher than assumed, as presented mainly in the form of primary glomerular disease. The presence of AKI/RPKD, hematuria, and ANS/ANP serves as a reliable indicator of non-diabetic renal pathology. In more ambiguous situations, factors such as a shorter duration of diabetes, absence of DRP, and a lower NLR value may assist clinicians in biopsy decision.

Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy

Clinical Characteristics of Diabetic Nephropathy in Patients with Type 2 Diabetic Mellitus Manifesting Heavy Proteinuria: a Retrospective Analysis of 220 Cases.

Characteristics of Diabetic Nephropathy Patients Without Diabetic Retinopathy A Retrospective Observational Study

Depiction of Immune Heterogeneity of Peripheral Blood from Patients with Type II Diabetic Nephropathy Based on Mass Cytometry

Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria

Renal Histologic Changes and the Outcome in Patients with Diabetic Nephropathy.

A retrospective cohort study of clinical characteristics and outcomes of type 2 diabetic patients with kidney disease

The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes

Study on the non-diabetic kidney disease in type 2 diabetes mellitus

Clinical Features and Long-Term Outcomes of Diabetic Kidney Disease - A Prospective Cohort Study from China

Chronic Complications in Patients of Type 2 Diabetes with Diabetic Nephropathy

The Prevalence and Clinicopathological Spectrum of Nondiabetic Renal Disease in Patients with Diabetes in a Tertiary Care Center

Risk evaluation for diabetic retinopathy in Chinese renal-biopsied type 2 diabetes mellitus patients

Evolving spectrum of diabetic nephropathy

Correlation between retinal vascular geometric parameters and pathologically diagnosed type 2 diabetic nephropathy

Determinants of non-diabetic kidney diseases in type 2 diabetic patients: Twenty years of single center experience

Clinical Studie of Diabetic Nephropathy with Urinary Protein Negative in Patients with Type 2 Diabetes Mellitus

[Renal Insufficiency and Its Associated Factors in Type 2 Diabetic Patients with Normoalbuminuria.].

Impact of Diabetic Nephropathy on Pulmonary Function and Clinical Outcomes

[Validation and comparison of diabetic retinopathy-based diagnostic models for diabetic nephropathy]

Anemia in Patients with Diabetic Nephropathy